Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Appointments

Latest From Appointments

Appointments: G1 Therapeutics, Breath Therapeutics, Fortress Biotech, Freeline Therapeutics, Enterome and Symic Bio

GSK's former CEO Sir Andrew Witty has joined the board of directors of the oncology company, G1 Therapeutics. This week's roundup also includes CEO appointments by Fortress Biotech, Freeline Therapeutics and BridgeSat, in addition to various other high-level appointments by Nabriva Therapeutics, Caribou Biosciences, Symic Bio and Breath Therapeutics.

BioPharmaceutical Appointments

Asia Executives To Watch: FDA Names New India Director

FDA has named a new head for India while Roche has appointed a new VP for its anti-infectives and specialty care business unit in China. Personnel changes have also been effected at Bayer, Cook Medical, and the biopharma startup Kira Therapeutics.

Appointments StartUps and SMEs

Stada CEO & CFO Resign; Rumors Circle Of A New Takeover bid

Stada's top brass have quit following rumors earlier this week of a fresh takeover bid for the generic company from equity groups Bain and Cinven; ex-Boehringer executive Tjeenk Willink has been named incoming CEO.

M & A Appointments

Appointments: Astellas, BIO, Hikma, Eton, Akili and Oxford BioDynamics

This week's roundup includes CEO appointments by Eton Pharmaceuticals, the Biotechnology Innovation Organization and Hikma, in addition to various other high-level appointments by Astellas, Akili Interactive Labs and Oxford BioDynamics.

BioPharmaceutical Appointments

Appointments: New Executives At GSK, Leo Pharma, Valeant, Verona, Ocugen And Peptinnovate

This week’s crop of executive appointments include confirmation that GSK’s new pharma head will start work in September, a new head of Leo Pharma’s US business, and a head of investor relations at Valeant.

Appointments BioPharmaceutical

Asia Executives To Watch: New FDA China Director Named Amid ICH Push

The US FDA has sent its country director from Peru to build a closer relationship with the China FDA, while the CFDA's own medical device center is also going through a series of leadership changes.

China Appointments

Appointments: Tiziana, Ergomed, Kymab, Crescendo, Ablynx, Axcella and Alexion.

This week's roundup includes CEO appointments by Tiziana and Ergomed and executive appointments by Crescendo Biologics, Ablynx, Alexion and Axcella. In addition to this, Oxford BioTherapeutics and Kymab have announced board appointments.

Appointments BioPharmaceutical

Appointments: Prana, Octapharma, ABPI, Gamida and Allergy Therapeutics

This week's roundup includes senior appointments by Prana Biotechnology, Octapharma, Silence Therapeutics and ABPI, in addition to board appointments by Gamida Cell and Allergy Therapeutics.

Appointments BioPharmaceutical

Appointments: Eli Lilly, Alexion, Actelion, Polyphor, Constellation, Bone Therapeutics and Allied Minds

This week's roundup includes the announced retirement of Lilly's CFO, high-level appointments by Alexion Pharmaceuticals, Actelion and Constellation, and board elections by Wilson Therapeutics, Bone Therapeutics and Atlantic Healthcare.

BioPharmaceutical Appointments

Sun Recruits Ex-Cipla Manufacturing Veteran In Compliance Push

Sun Pharma is believed to have tapped Davinder Singh, ex-Cipla technical director and veteran in the manufacturing space, as it tackles compliance-related challenges at its manufacturing sites.

Compliance Commercial

Asia Executives To Watch: Changes At MSD China, CFDA

A new month has ushered in a flurry of executive changes at MSD in China, Toyama Taisho in Japan, and also a new line up of officials at the China FDA.

Appointments China

Appointments: IFPMA, Merck, Chromocell, Kymab, GW Pharmaceuticals, Fortuna Fix and Motif

This week's roundup includes high level appointments by Merck KGaA, Chromocell Corporation, Kymab and GW Pharmaceuticals, in addition to board appointments by Fortuna Fix and Motif Bio.

Appointments BioPharmaceutical
See All